Urol. praxi. 2017;18(1):14-16 | DOI: 10.36290/uro.2017.004

Indications, results, and significance of early repeat transurethral resection of bladder tumours

MUDr. Antonín Brisuda, FEBU
Urologická klinika FN Motol, 2. LF UK, Praha

Early repeat transurethral resection of bladder tumour is used to refine staging of the disease and to rule out residual tumour left

behind in the bladder after primary resection. The review article deals with the indications for and results of early repeat resection,

and presents the experience of the author’s workplace.

Keywords: urinary bladder, urothelial carcinoma, transurethral resection

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brisuda A. Indications, results, and significance of early repeat transurethral resection of bladder tumours. Urol. praxi. 2017;18(1):14-16. doi: 10.36290/uro.2017.004.
Download citation

References

  1. Internetový portál www.uroweb.cz
  2. Dvořáček J, Babjuk M. Onkourologie. Praha: Galén, Karolinum 2005: 589 s.
  3. Kirkali Z, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology, 2005; 66(Suppl.6A): 4-34. Go to original source... Go to PubMed...
  4. Hanuš T, Macek P. Urologie pro mediky. Karolinum 2015: 305 s.
  5. Brausi M, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol, 2002; 41: 523. Go to original source... Go to PubMed...
  6. Mariappan P, et al. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int, 2012; 109: 1666. Go to original source... Go to PubMed...
  7. Babjuk M, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2016 Jun 17. pii: S0302-2838(16)30249-4. Go to PubMed...
  8. Herr HW, et al. Quality control in transurethral resection of bladder tumours. BJU Int, 2008; 102: 1242. Go to original source... Go to PubMed...
  9. Mariappan P, et al. Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010 May; 57(5): 843-849. Go to original source... Go to PubMed...
  10. Jahnson S, et al. Results of second-look resection after primary resection of T1 tumour of the urinary bladder. Scand J Urol Nephrol, 2005; 39: 206. Go to original source...
  11. Grimm MO, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol, 2003; 170: 433. Go to original source... Go to PubMed...
  12. Schwaibold HE, et al. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006; 97: 1199-1201. Go to original source... Go to PubMed...
  13. Lazica DA, et al. Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university center. Urol Int, 2014; 92: 131. Go to original source... Go to PubMed...
  14. Divrik RT. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 2010; 58: 185-190. Go to original source... Go to PubMed...
  15. Sfakianos JP. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin. J Urol. 2014 Feb; 191(2): 341-345. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.